Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 696-026-0 | CAS number: 1395383-69-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- August 7, 1979 to October 4, 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Well-documented pre-guideline study without GLP, testing protocol similar to OECD 401
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 979
- Report date:
- 1979
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 401 (Acute Oral Toxicity)
- Deviations:
- yes
- Remarks:
- pre-guideline and pre-GLP study
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Test material form:
- liquid
- Details on test material:
- Batch: 502834
Constituent 1
Test animals
- Species:
- rat
- Strain:
- other: Tif: RAIf (SPF)
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Healthy random bred rats of 7-8 weeks age were raised on the premises and kept at room temperature of 22 +/- 2 deg. C, at relatie humidity of 55 +/- 10% and on a 10 hour light cylce day. They received ad libitum rat food (supplier: NAFAG, Gossau, Switzerland) and water. They were adapted to the laboratory for a minimum of 4 days before treatment. During treatment and observation period the animals were housed in groups of 5 animals in Macrolon cages type 3. Animals were individually marked with picric acid.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- polyethylene glycol
- Details on oral exposure:
- MAXIMUM DOSE VOLUME APPLIED: 20 mL/kg bw.
- Doses:
- 600, 1000, 2000 and 5000 mg/kg bw
- No. of animals per sex per dose:
- 5 males and 5 females
- Details on study design:
- - Prior to dosing the animals were fasted overnight.
- Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations: 1 / hour for the first 5 hours, thereafter at least 1 / day. Body weight determination 1 / week
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight - Statistics:
- LD50 including 95% confidence intervals were calculated by the logit model
Results and discussion
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- 2 026 mg/kg bw
- Based on:
- test mat.
- 95% CL:
- > 1 508 - < 3 096
- Mortality:
- Males: 5000 mg/kg 1 ( 3 hours), 3 ( 5 hours), 1 ( 24 hours) : 5/5
Males: 2000 mg/kg 1 ( 24 hours) : 1/5
Males: 1000 mg/kg : 0/5
Males: 600 mg/kg : 0/5
Females: 5000 mg/kg 3 ( 3 hours), 2 ( 5 hours) : 5/5
Females: 2000 mg/kg 2 ( 24 hours), 1 ( day 2) : 3/5
Females: 1000 mg/kg 1 ( 24 hours), 1 (day 6) : 1/5
Females: 600 mg/kg : 0/5 - Clinical signs:
- other: Animals treated with 5000 mg/kg bw showed severe sedation, a moderate effect on ruffled fur and cynosis and slight effects as dyspnoea, exophthalmos, convulsion and curved body position on the day of treatment. Animals treated with 2000 mg/kg bw showed a
- Gross pathology:
- no findings observed in the dead and killed animals
Applicant's summary and conclusion
- Interpretation of results:
- relatively harmless
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The acute toxicity is similar for males and females. The LD50 is 2026 (1508-3096) mg/kg bw.
- Executive summary:
The acute toxicity has been investiagated in a pre-guideline and pre-GLP study performed and recorded similarly to the later standards. The doses selected were 5000 -2000 -1000 and 600 mg/kg bw. Each 5 male and 5 female animals were treated by gavage application with the test substance suspended in PEG 400. Mortality was 100% at the top dose in females and 80% in the top dose in males.Mortality at the lower dose was 20% in males and 60% in females. Mortality was 0% in males and 20% in females at 1000 mg/kg bw. The low dose was without mortality in males and females. At all doses there were the usual clinical symptoms in animals of both sexes. Mortality occurred within 4 days after treatment. The LD50 calculated is 2026 mg/kg bw (95% confidence limits are 1508 -3096 mg/kg).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
Въпреки че ECHA предоставя много онлайн материали на Вашия език, част от страницата е налична само на английски език. Научете повече за многоезиковата практика на ECHA.
Добре дошли на уебсайта на ECHA. Уебсайтът не се поддържа напълно от Internet Explorer 7 (и по-стари версии). Обновете Internet Explorer с по-нова версия.
За да гарантираме, че се възползвате максимално от функциите на нашия уебсайт, сме въвели „бисквитки“.
FНаучете повече как използваме бисквитките.